These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 14745303)

  • 1. Improvement in quality of life after treatment for alcohol dependence with acamprosate and psychosocial support.
    Morgan MY; Landron F; Lehert P;
    Alcohol Clin Exp Res; 2004 Jan; 28(1):64-77. PubMed ID: 14745303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The European NEAT program: an integrated approach using acamprosate and psychosocial support for the prevention of relapse in alcohol-dependent patients with a statistical modeling of therapy success prediction.
    Pelc I; Ansoms C; Lehert P; Fischer F; Fuchs WJ; Landron F; Pires Preto AJ; Morgan MY
    Alcohol Clin Exp Res; 2002 Oct; 26(10):1529-38. PubMed ID: 12394286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A pragmatic trial of acamprosate in the treatment of alcohol dependence in primary care.
    Kiritzé-Topor P; Huas D; Rosenzweig C; Comte S; Paille F; Lehert P
    Alcohol Alcohol; 2004; 39(6):520-7. PubMed ID: 15304381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quality of life depends on the drinking pattern in alcohol-dependent patients.
    Daeppen JB; Faouzi M; Sanchez N; Rahhali N; Bineau S; Bertholet N
    Alcohol Alcohol; 2014; 49(4):457-65. PubMed ID: 24863264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Health-related quality of life in children and adolescents who have a diagnosis of attention-deficit/hyperactivity disorder.
    Klassen AF; Miller A; Fine S
    Pediatrics; 2004 Nov; 114(5):e541-7. PubMed ID: 15520087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The efficacy of acamprosate in the maintenance of abstinence in alcohol-dependent individuals: results of a meta-analysis.
    Mann K; Lehert P; Morgan MY
    Alcohol Clin Exp Res; 2004 Jan; 28(1):51-63. PubMed ID: 14745302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patient-reported quality of life after abdominal aortic aneurysm surgery: a prospective comparison of endovascular and open repair.
    Aljabri B; Al Wahaibi K; Abner D; Mackenzie KS; Corriveau MM; Obrand DI; Meshefedjian G; Steinmetz OK
    J Vasc Surg; 2006 Dec; 44(6):1182-1187. PubMed ID: 17145419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alcohol-use disorders and depression: results from individual patient data meta-analysis of the acamprosate-controlled studies.
    Lejoyeux M; Lehert P
    Alcohol Alcohol; 2011; 46(1):61-7. PubMed ID: 21118900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is acamprosate use in alcohol dependence treatment reflected in improved subjective health status outcomes beyond cognitive behavioural therapy alone?
    Feeney GF; Connor JP; McD Young R; Tucker J; McPherson A
    J Addict Dis; 2006; 25(4):49-58. PubMed ID: 17088225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized, multicentre, open-label, comparative trial of disulfiram, naltrexone and acamprosate in the treatment of alcohol dependence.
    Laaksonen E; Koski-Jännes A; Salaspuro M; Ahtinen H; Alho H
    Alcohol Alcohol; 2008; 43(1):53-61. PubMed ID: 17965444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Timecourse of health-related quality of life as determined 3, 6 and 12 months after stroke. Relationship to neurological deficit, disability and depression.
    Suenkeler IH; Nowak M; Misselwitz B; Kugler C; Schreiber W; Oertel WH; Back T
    J Neurol; 2002 Sep; 249(9):1160-7. PubMed ID: 12242533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Why is disulfiram superior to acamprosate in the routine clinical setting? A retrospective long-term study in 353 alcohol-dependent patients.
    Diehl A; Ulmer L; Mutschler J; Herre H; Krumm B; Croissant B; Mann K; Kiefer F
    Alcohol Alcohol; 2010; 45(3):271-7. PubMed ID: 20348436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of early and late compliance on the effectiveness of acamprosate in the treatment of alcohol dependence.
    Koeter MW; van den Brink W; Lehert P
    J Subst Abuse Treat; 2010 Oct; 39(3):218-26. PubMed ID: 20627222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined acamprosate and naltrexone, with cognitive behavioural therapy is superior to either medication alone for alcohol abstinence: a single centres' experience with pharmacotherapy.
    Feeney GF; Connor JP; Young RM; Tucker J; McPherson A
    Alcohol Alcohol; 2006; 41(3):321-7. PubMed ID: 16467406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Evaluation of health-related quality of life in dialysis patients. Personal experience using questionnaire SF-36].
    Kusztal M; Nowak K; Magott-Procelewska M; Weyde W; Penar J
    Pol Merkur Lekarski; 2003 Feb; 14(80):113-7. PubMed ID: 12728668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of oral acamprosate on abstinence in patients with alcohol dependence in a double-blind, placebo-controlled trial: the role of patient motivation.
    Mason BJ; Goodman AM; Chabac S; Lehert P
    J Psychiatr Res; 2006 Aug; 40(5):383-93. PubMed ID: 16546214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective evaluation of health related quality of life for pediatric patients with ureteropelvic junction obstruction.
    Parekh AD; Thomas JC; Trusler L; Ankerst DP; Deshpande JK; Adams MC; Pope JC; Brock JW
    J Urol; 2008 Nov; 180(5):2171-5; discussion 2175-6. PubMed ID: 18804796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sustained improvement in patient-reported outcomes during long-term fesoterodine treatment for overactive bladder symptoms: pooled analysis of two open-label extension studies.
    Kelleher CJ; Dmochowski RR; Berriman S; Kopp ZS; Carlsson M
    BJU Int; 2012 Aug; 110(3):392-400. PubMed ID: 22129365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Health related quality of life after orthotopic neobladder construction and its comparison with normative values in the Japanese population.
    Yoneda T; Adachi H; Urakami S; Kishi H; Shigeno K; Shiina H; Igawa M
    J Urol; 2005 Nov; 174(5):1944-7. PubMed ID: 16217363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acamprosate in the treatment of alcohol dependence: clinical and economic considerations.
    Mason BJ; Crean R
    Expert Rev Neurother; 2007 Nov; 7(11):1465-77. PubMed ID: 17997696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.